News about Global Pharma

ESTEVE Acquires Regis Technologies to Strengthen US Footprint

This acquisition enables ESTEVE to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the US.

Global Pharma | 31/07/2025 | By Mrinmoy Dey |  225

Celltrion to Acquire US Biologics Plant to Counter Potential Pharma Tariffs

Celltrion has been selected as the preferred bidder to acquire a large biologics manufacturing plant in the United States —a strategic move aimed at insulating the company from potential US pharmaceutical tariffs.

Global Pharma | 30/07/2025 | By Dineshwori |  600

Sandoz to Acquire Just-Evotec Biologics in USD 300 Million Deal

Sandoz has signed a non-binding term sheet with Evotec SE, paving the way for the potential acquisition of Just–Evotec Biologics EU SAS for approximately USD 300 million.

Global Pharma | 30/07/2025 | By Dineshwori |  390

Cellipont Bioservices and CellVax Therapeutics Expand Partnership for cGMP Manufacturing of FK-GI101

Cellipont Bioservices and CellVax Therapeutics have expanded their partnership to advance cGMP manufacturing and clinical development of FK-GI101, a personalised immunotherapy targeting gastrointestinal cancers, building on prior collaboration for prostate cancer therapy FK-PC101.

Global Pharma | 30/07/2025 | By Mrinmoy Dey |  230

Agilent Technologies Unveils New Biopharma Experience Center in Hyderabad

Agilent Technologies has launched a new Biopharma Experience Center in Hyderabad, Telangana, as part of its broader three-to-five-year India growth strategy.

Global Pharma | 30/07/2025 | By Dineshwori |  321

Zydus Acquires 85.6 Percent Stake in Amplitude Surgical for EUR 256 Million

Zydus Lifesciences Ltd. has completed the EUR 256 million acquisition of an 85.6 percent stake in France-based Amplitude Surgical, marking a strategic move to strengthen its global presence in the orthopaedics space.

Global Pharma | 30/07/2025 | By Mrinmoy Dey |  197

Novo Nordisk Appoints Maziar Mike Doustdar as New CEO, Announces Key Organisational Changes

Maziar Mike Doustdar will succeed Lars Fruergaard Jørgensen, who will step down as President and Chief Executive Officer of Novo Nordisk next month.

Global Pharma | 30/07/2025 | By Dineshwori |  663

Johnson and Johnson Unveils AI Solution for Bunion Surgery, Seeks FDA Nod to Expand TREMFYA Label

Johnson and Johnson MedTech has announced the launch of the VIRTUGUIDE System, an advanced AI-powered solution designed to support Lapidus procedures—a common type of bunion surgery.

Global Pharma | 30/07/2025 | By Dineshwori |  185

Novo Nordisk Cuts Annual Outlook Again as Wegovy Supply Woes Persist

Shares of Novo Nordisk fell sharply after the company once again lowered its annual forecast, citing ongoing supply challenges for its blockbuster obesity drug Wegovy. Despite a 25% jump in second-quarter sales and a 28% rise in net profit, the Danish drugmaker scaled back expectations for full-year operating profit and sales growth.

Global Pharma | 30/07/2025 | By Darshana |  135

Novartis India Appoints DC Dave and Co as Cost Auditors for FY 2025-26

Novartis India has appointed M/s. DC Dave and Co., a firm of practicing cost accountants, as the cost auditors of the company for the financial year 2025–26.

Global Pharma | 29/07/2025 | By Dineshwori |  171